A Study to Evaluate Skin Irritation and Photo Irritation of JNJ 10229570-AAA on Intact Skin of Japanese Healthy Male Participants

NCT01494714 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: JNJ 10229570-AAA 1.2% cream
DRUG: JNJ 10229570-AAA 2.4% cream
DRUG: JNJ 10229570-AAA 3.6% cream
DRUG: Color-matched vehicle in a cream formulation containing 0 mg of JNJ 10229570-AAA
DRUG: Petroleum jelly

Sponsor

Janssen Pharmaceutical K.K.